Apotex vs. the Commissioner of Lobbying: where can it go from here?

News | TESSIE SANCI
Published: Wednesday, 12/20/2017 3:37 pm EST
Last Updated: Wednesday, 12/20/2017 3:57 pm EST

Hill Times file photo

The Office of the Commissioner of Lobbying is in the middle of a court challenge from Apotex. The pharmaceutical company, founded by the late Barry Sherman, filed for a judicial review earlier this year to halt the probe.

To View the rest of this article, please choose one of the following

If you are already a subscriber

Subscribe to The Lobby Monitor

Sign Up for a free trial

For instant access to the website.

On Queen Street: New independent shop aims to make GR accessible to marginalized groups
Dec. 13, 2024 12:00 am.
VIEW
Industry lobbyists prepare for second round of Trump trade policy
Dec. 12, 2024 12:00 am.
VIEW
‘It’s not just about wildfires’: Canada’s fire chiefs advocate for National Fire Administration and federal funding
Dec. 11, 2024 12:00 am.
VIEW
Communication Reports: Dec. 2, 2024, to Dec. 8, 2024
Dec. 10, 2024 12:00 am.
VIEW
Several energy and natural resources companies join registry
Dec. 09, 2024 12:00 am.
VIEW

SEE A SAMPLE

READY TO SUBSCRIBE?

Lobby Monitor Subscribers receive:

·
Analysis of Lobbying campaigns and the people behind them
·
Detailed Reports on Lobby Registry activity in an easy to read format
·
Profiles of Key players in the industry in Ottawa and Washington
·
Best Practices and insider tips

These key people read the Lobby Monitor and make decisions that could affect your business:

·
Company CEOs, senior executives who hire GR specialists
·
Law firms and GR firms

·
Public Relations specialists

·
Executives and senior staff

·
Industry and association professionals

·
Academics, researchers and advisers

·
Canadian government leaders, policy experts and senior bureaucrats

·
Provincial government and senior bureaucrats

For more information about The Lobby Monitor, click here or call 613.688.8822.

Apotex vs. the Commissioner of Lobbying: where can it go from here?

To View the rest of this article, please choose one of the following

If you are already a subscriber

Subscribe to The Lobby Monitor

Sign Up for a free trial

Inside The Lobby Monitor

Subscribers

More Info

Hill Times Publishing

Username
Password